UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sacral neuromodulation for lower urinary tract dysfunction

World journal of urology, 2012-08, Vol.30 (4), p.445-450

2012

Volltextzugriff (PDF)

Advances in the role of sacral nerve neuromodulation in lower urinary tract symptoms

International Urogynecology Journal, 2010-12, Vol.21 (Suppl 2), p.467-474

Van Kerrebroeck, Philip E. V.

2010

Volltextzugriff (PDF)

DOuble LOngitudinal Megapreputium Incision TEchnique: The DOLOMITE

Urology (Ridgewood, N.J.), 2014-05, Vol.83 (5), p.1149-1154

2014

Volltextzugriff (PDF)

Scrotal Approach to Both Palpable and Impalpable Undescended Testes: Should It Become Our First Choice?

Urology (Ridgewood, N.J.), 2010-07, Vol.76 (1), p.73-76

2010

Volltextzugriff (PDF)

The efficacy of mirabegron in the treatment of urgency and the potential utility of combination therapy

Therapeutic Advances in Urology, 2018-08, Vol.10 (8), p.243-256

2018

Volltextzugriff (PDF)

The effect of indomethacin on the muscarinic induced contractions in the isolated normal guinea pig urinary bladder

BMC urology, 2013-02, Vol.13 (1), p.8-8, Article 8

2013

Volltextzugriff (PDF)

Does Conservative Management Really Benefit Patients with OAB?

Current urology reports, 2012-10, Vol.13 (5), p.348-355

Van Kerrebroeck, Philip E. V.

2012

Volltextzugriff (PDF)

Lipid Peroxidation Product 4-Hydroxynonenal Contributes to Bladder Smooth Muscle Damage

Urology (Ridgewood, N.J.), 2008-05, Vol.71 (5), p.974-978

2008

Volltextzugriff (PDF)

Considerations for the management of urgency symptoms in patients with overactive bladder syndrome

World journal of urology, 2009-12, Vol.27 (6), p.755-763

2009

Volltextzugriff (PDF)

Desmopressin in the Treatment of Nocturia: A Double-Blind, Placebo-Controlled Study

European urology, 2007-07, Vol.52 (1), p.221-229

2007

Volltextzugriff (PDF)

Urologists' referral attitude for sacral neuromodulation for treating refractory idiopathic overactive bladder syndrome: Discrete choice experiment

Neurourology and urodynamics, 2014-11, Vol.33 (8), p.1240-1246

2014

Volltextzugriff (PDF)

Protocol for a prospective neuroimaging study investigating the supraspinal control of lower urinary tract function in healthy controls and patients with non-neurogenic lower urinary tract symptoms

BMJ open, 2014-05, Vol.4 (5), p.e004357-e004357

2014

Volltextzugriff (PDF)

Nocturia: New Directions

Neurourology and urodynamics, 2011-06, Vol.30 (5), p.700-703

2011

Volltextzugriff (PDF)

Detrusor Underactivity and the Underactive Bladder: A New Clinical Entity? A Review of Current Terminology, Definitions, Epidemiology, Aetiology, and Diagnosis

European urology, 2014-02, Vol.65 (2), p.389-398

2014

Volltextzugriff (PDF)

IL-10 Update on Management of Overactive Bladder

The Japanese Journal of Urology, 2007/02/20, Vol.98(2), pp.63

Van Kerrebroeck, Philip E. V.

2007

Volltextzugriff (PDF)

A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder

Urology (Ridgewood, N.J.), 2013-08, Vol.82 (2), p.313-320

2013

Volltextzugriff (PDF)

The value of urodynamic tools to guide patient selection in sacral neuromodulation

World journal of urology, 2015-11, Vol.33 (11), p.1889-1895

2015

Volltextzugriff (PDF)

Long-term Safety and Efficacy of Single-tablet Combinations of Solifenacin and Tamsulosin Oral Controlled Absorption System in Men with Storage and Voiding Lower Urinary Tract Symptoms: Results from the NEPTUNE Study and NEPTUNE II Open-label Extension

European urology, 2015-02, Vol.67 (2), p.262-270

2015

Volltextzugriff (PDF)

Pharmacotherapy for Nocturia

Current urology reports, 2018-01, Vol.19 (1), p.8-8, Article 8

2018

Volltextzugriff (PDF)

Combination Therapy with Solifenacin and Tamsulosin Oral Controlled Absorption System in a Single Tablet for Lower Urinary Tract Symptoms in Men: Efficacy and Safety Results from the Randomised Controlled NEPTUNE Trial

European urology, 2013-12, Vol.64 (6), p.1003-1012

2013

Volltextzugriff (PDF)

Clinical Efficacy, Safety, and Tolerability of Once-Daily Fesoterodine in Subjects with Overactive Bladder

European urology, 2007-10, Vol.52 (4), p.1204-1212

2007

Volltextzugriff (PDF)

Efficacy and Safety of Solifenacin Plus Tamsulosin OCAS in Men with Voiding and Storage Lower Urinary Tract Symptoms: Results from a Phase 2, Dose-finding Study (SATURN)

European urology, 2013-09, Vol.64 (3), p.398-407

2013

Volltextzugriff (PDF)

Female Pelvic Medicine: Challenging Cases with Expert Commentary

1, 2021

Volltextzugriff (PDF)

Reply

Urology (Ridgewood, N.J.), 2013, Vol.82 (2), p.320-320

Van Kerrebroeck, Philip E.V., M.D., Ph.D., M.MSc

2013

Volltextzugriff (PDF)

Onset of action of the β3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder

World journal of urology, 2014-12, Vol.32 (6), p.1565-1572

2014

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Full Text

ThemaUrology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(34)
Bücher
(1)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Urology & Nephrology
(26)
Humans
(22)
Male
(15)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Middle Aged
(12)
Nephrology. Urinary Tract Diseases
(12)
Aged
(10)
Female
(10)
Medicine
(10)
Medicine & Public Health
(10)
Treatment Outcome
(10)
Urinary Tract. Prostate Gland
(10)
Lower Urinary Tract Symptoms
(9)
Urinary System Involvement In Other Diseases. Miscellaneous
(9)
Adult
(7)
Double-Blind Method
(7)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sacral neuromodulation for lower urinary tract dysfunction

Advances in the role of sacral nerve neuromodulation in lower urinary tract symptoms

DOuble LOngitudinal Megapreputium Incision TEchnique: The DOLOMITE

Scrotal Approach to Both Palpable and Impalpable Undescended Testes: Should It Become Our First Choice?

The efficacy of mirabegron in the treatment of urgency and the potential utility of combination therapy

The effect of indomethacin on the muscarinic induced contractions in the isolated normal guinea pig urinary bladder

Does Conservative Management Really Benefit Patients with OAB?

Lipid Peroxidation Product 4-Hydroxynonenal Contributes to Bladder Smooth Muscle Damage

Considerations for the management of urgency symptoms in patients with overactive bladder syndrome

Desmopressin in the Treatment of Nocturia: A Double-Blind, Placebo-Controlled Study

Urologists' referral attitude for sacral neuromodulation for treating refractory idiopathic overactive bladder syndrome: Discrete choice experiment

Protocol for a prospective neuroimaging study investigating the supraspinal control of lower urinary tract function in healthy controls and patients with non-neurogenic lower urinary tract symptoms

Nocturia: New Directions

Detrusor Underactivity and the Underactive Bladder: A New Clinical Entity? A Review of Current Terminology, Definitions, Epidemiology, Aetiology, and Diagnosis

IL-10 Update on Management of Overactive Bladder

A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder

The value of urodynamic tools to guide patient selection in sacral neuromodulation

Long-term Safety and Efficacy of Single-tablet Combinations of Solifenacin and Tamsulosin Oral Controlled Absorption System in Men with Storage and Voiding Lower Urinary Tract Symptoms: Results from the NEPTUNE Study and NEPTUNE II Open-label Extension

Pharmacotherapy for Nocturia

Combination Therapy with Solifenacin and Tamsulosin Oral Controlled Absorption System in a Single Tablet for Lower Urinary Tract Symptoms in Men: Efficacy and Safety Results from the Randomised Controlled NEPTUNE Trial

Clinical Efficacy, Safety, and Tolerability of Once-Daily Fesoterodine in Subjects with Overactive Bladder

Efficacy and Safety of Solifenacin Plus Tamsulosin OCAS in Men with Voiding and Storage Lower Urinary Tract Symptoms: Results from a Phase 2, Dose-finding Study (SATURN)

Female Pelvic Medicine: Challenging Cases with Expert Commentary

Reply

Onset of action of the β3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder

Aktive Filter

Suchergebnisse filtern